Secured Loan Note Applications

Posted on: Wednesday, July 01, 2009

Meldex clarifies how Qualifying Shareholders can apply for the Secured Loan Note ("SLN") offer, and how the application procedure operates for shares held with brokers in nominee accounts.
 
All Qualifying Shareholders are entitled to receive a copy of the 50 page SLN Issue Document and the 4 page Application Form so that they can make an informed decision as to whether to apply for the SLN offer.
 
The Company has become aware that certain brokers have decided not to pass all of this information onto their Meldex Shareholders.

Any Qualifying Shareholder who has not received a copy of the SLN documentation should contact the Company by calling 01223 394250 or by sending an email to BJM@meldexinternational.com 
 
Meldex confirms that Qualifying Shareholders whose shares are held by brokers in nominee accounts may choose to apply for SLN Units directly and without going through their broker.

Further details of the SLN offer are available here: Secured Loan Note

Other current news items

Distribution Agreement for Menoflavon® in Jordan
Posted on: Tuesday, May 25, 2010

Kudos™ Licensing Agreement
Posted on: Friday, May 14, 2010

Distribution Agreement for Menoflavon® in Singapore
Posted on: Thursday, April 15, 2010

Meldex International PLC 2008 Financial Statements
Posted on: Thursday, January 07, 2010

Announcement: Execution of Memorandum of Understanding
Posted on: Tuesday, December 08, 2009

Distribution Agreement for Menoflavon® in the Netherlands
Posted on: Tuesday, November 03, 2009

Restoration of Registrar Services
Posted on: Thursday, October 15, 2009

Company Update
Posted on: Tuesday, October 13, 2009

Distribution Agreement for Menoflavon® in Canada
Posted on: Friday, October 02, 2009

Company Update
Posted on: Friday, September 25, 2009

Distribution Agreement for Menoflavon® in Austria
Posted on: Friday, September 18, 2009

Update on the Secured Loan Note Offer
Posted on: Wednesday, September 02, 2009

Result of Annual General Meeting
Posted on: Friday, August 28, 2009

Distribution Agreement for Menoflavon® and Melprotect® in United Arab Emirates
Posted on: Monday, August 24, 2009

Secured Loan Note Update and Notice of AGM
Posted on: Wednesday, August 05, 2009

Secured Loan Note update
Posted on: Friday, July 24, 2009

Extension to Secured Loan Note offer deadline
Posted on: Wednesday, July 22, 2009

Appointment of Consultant Project Manager
Posted on: Thursday, July 16, 2009

Distribution Agreement for Menoflavon® in Germany
Posted on: Friday, July 10, 2009

Appointment of Consultant Project Manager
Posted on: Friday, July 10, 2009

Proceedings issued against former Directors
Posted on: Saturday, July 04, 2009

Collaboration Agreement for Meltums™ Pharma Development
Posted on: Thursday, July 02, 2009

Menoflavon® Distribution Agreements
Posted on: Monday, June 29, 2009

Launch of Secured Loan Note Offer
Posted on: Thursday, June 25, 2009

Distribution Agreement for Menoflavon® in Belgium
Posted on: Wednesday, June 24, 2009

Company Update
Posted on: Monday, June 15, 2009

Product Availability Matrix
Posted on: Thursday, June 11, 2009

Cancellation of Share Options
Posted on: Wednesday, June 03, 2009

Oradisc™ Benzocaine now at Regulatory stage
Posted on: Tuesday, May 05, 2009

Hintz Joint Venture announcement
Posted on: Thursday, April 09, 2009